date,title,source
Oct-17-18,"BioLineRx, High Potential Near Term Catalysts, Analysts Review and Target",ACCESSWIRE
Oct-19-18,BioLineRx Presents Top-line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress,PR Newswire
Nov-01-18,"BioLineRx to Report Third Quarter 2018 Results on November 8, 2018",PR Newswire
Nov-08-18,BioLineRx Reports Significant Progress Across Oncology Programs and Provides Third Quarter Financial Update,PR Newswire
Nov-16-18,"Recent Analysis Shows BioLineRx, Interlink Electronics, IMV INC, PAR Technology, Hudson Global, and Identiv Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-20-18,New Healthcare Trends Have Investors Looking at 4 Stocks,ACCESSWIRE
Nov-20-18,BioLineRx Announces Receipt of FDA Biological Product Designation for Novel Cancer Immunotherapy Candidate AGI-134,PR Newswire
